BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7678397)

  • 21. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
    Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
    Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases.
    Koutsikos J; Leondi A
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1392-3; author reply 1394-5. PubMed ID: 18438661
    [No Abstract]   [Full Text] [Related]  

  • 24. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
    Schoeneich G; Palmedo H; Dierke-Dzierzon C; Müller SC; Biersack HJ
    Scand J Urol Nephrol; 1997 Oct; 31(5):445-8. PubMed ID: 9406304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
    Serafini AN
    Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pain palliative therapy in women with breast cancer osseous metastatic disease and the role of specific serum cytokines as prognostic factors.
    Iakovou I; Doumas A; Badiavas K; Mpalaris V; Frangos S; Farmakis G
    Cancer Biother Radiopharm; 2014 Apr; 29(3):116-23. PubMed ID: 24392878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium.
    Porter AT; Ben-Josef E; Davis L
    Curr Opin Oncol; 1994 Nov; 6(6):607-10. PubMed ID: 7827173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radionuclide therapy of intractable bone pain: emphasis on strontium-89.
    Robinson RG; Preston DF; Spicer JA; Baxter KG
    Semin Nucl Med; 1992 Jan; 22(1):28-32. PubMed ID: 1589803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [153Sm-EDTMP for moderate and severe bone cancer pain].
    Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer therapy using bone-seeking isotopes.
    Lewington VJ
    Phys Med Biol; 1996 Oct; 41(10):2027-42. PubMed ID: 8912378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular radiotherapy.
    Buscombe J; Navalkissoor S
    Clin Med (Lond); 2012 Aug; 12(4):381-6. PubMed ID: 22930888
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDP.
    De Klerk JM; Zonnenberg BA; Blijham GH; Van Het Schip AD; Hoekstra A; Han SH; Quirijnen JM; Van Dijk A; Van Rijk PP
    Anticancer Res; 1997; 17(3B):1773-7. PubMed ID: 9179233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.
    Ketring AR
    Int J Rad Appl Instrum B; 1987; 14(3):223-32. PubMed ID: 3117736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palliative therapy with rhenium-186-HEDP for bone metastases of breast cancer.
    Guerra UP; Englaro E; Cattaruzzi E
    Tumori; 1997; 83(2):560-2. PubMed ID: 9226021
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP ].
    Dolezal J; Vizd'a J; Cermáková E
    Vnitr Lek; 2003 Mar; 49(3):189-93. PubMed ID: 12728593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
    Brenner W; Kampen WU; Kampen AM; Henze E
    J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of rhenium-188 HEDP in bone metastases therapy.
    Scheffler J; Derejko M; Bandurski T; Romanowicz G
    Nucl Med Rev Cent East Eur; 2003; 6(1):55-7. PubMed ID: 14600935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pain therapy with rhenium-186 HEDP in multiple bone metastases].
    Palmedo H; Bender H; Schomburg A; Grünwald F; Schöneich G; Zamorra P; Reichmann K; Dierke-Dzierzon C; Mallmann P; Biersack HJ
    Nuklearmedizin; 1996 Apr; 35(2):63-7. PubMed ID: 8721578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiopharmaceuticals in clinical trials.
    Holmes RA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
    Jiang CY; Zhu BL; Zhang YJ
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):118-21. PubMed ID: 7523052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.